Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Müller-Newen

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment|September 25, 2003
The cytokine receptor gp130: faithfully promiscuousGerhard Müller-Newen
European Journal of Cell Biology|October 1, 2011
Receptor fusion proteins for the inhibition of cytokinesDieter Schwache, Gerhard Müller-Newen
Cancers|November 23, 2019
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?Sabrina Ernst, Gerhard Müller-Newen
European Journal of Cell Biology|February 28, 2012
Cytokines and inflammationJürgen Floege, Bernhard Lüscher, Gerhard Müller-Newen
Cell Communication and Signaling : CCS|November 7, 2013
Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domainAnne Mohr, Dirk Fahrenkamp, Natalie Rinis, et al.
The Journal of Biological Chemistry|January 5, 2008
Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptorsSilke Metz, Gudrun Naeth, Peter C Heinrich, et al.
Journal of Leukocyte Biology|February 26, 2017
Development of platelets during steady state and inflammationGerhard Müller-Newen, Matthias B Stope, Thomas Kraus, et al.
Nature Structural & Molecular Biology|June 4, 2005
Bow to your partner for signalingHeike M Hermanns, Gerhard Müller-Newen, Peter C Heinrich, et al.
BMC Biotechnology|January 13, 2011
A receptor fusion protein for the inhibition of murine oncostatin MLiv Brolund, Andrea Küster, Sabrina Korr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 15, 2007
Characterization of cyclin L1 as an immobile component of the splicing factor compartmentAndreas Herrmann, Katrin Fleischer, Hanna Czajkowska, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Science'S STKE : Signal Transduction Knowledge Environment|September 25, 2003
The cytokine receptor gp130: faithfully promiscuousGerhard Müller-Newen
European Journal of Cell Biology|October 1, 2011
Receptor fusion proteins for the inhibition of cytokinesDieter Schwache, Gerhard Müller-Newen
Cancers|November 23, 2019
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?Sabrina Ernst, Gerhard Müller-Newen
European Journal of Cell Biology|February 28, 2012
Cytokines and inflammationJürgen Floege, Bernhard Lüscher, Gerhard Müller-Newen
Cell Communication and Signaling : CCS|November 7, 2013
Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domainAnne Mohr, Dirk Fahrenkamp, Natalie Rinis, et al.
The Journal of Biological Chemistry|January 5, 2008
Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptorsSilke Metz, Gudrun Naeth, Peter C Heinrich, et al.
Journal of Leukocyte Biology|February 26, 2017
Development of platelets during steady state and inflammationGerhard Müller-Newen, Matthias B Stope, Thomas Kraus, et al.
Nature Structural & Molecular Biology|June 4, 2005
Bow to your partner for signalingHeike M Hermanns, Gerhard Müller-Newen, Peter C Heinrich, et al.
BMC Biotechnology|January 13, 2011
A receptor fusion protein for the inhibition of murine oncostatin MLiv Brolund, Andrea Küster, Sabrina Korr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 15, 2007
Characterization of cyclin L1 as an immobile component of the splicing factor compartmentAndreas Herrmann, Katrin Fleischer, Hanna Czajkowska, et al.
Pageof 10